Microbot Medical
MBOT
25 hedge funds and large institutions have $6.77M invested in Microbot Medical in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
28% more capital invested
Capital invested by funds: $5.28M → $6.77M (+$1.49M)
0.4% more ownership
Funds ownership: 10.78% → 11.18% (+0.4%)
4% less funds holding
Funds holding: 26 → 25 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$170K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$142K |
| 3 |
Millennium Management
New York
|
+$96.6K |
| 4 |
IMA
Investment Management Associates
Greenwood Village,
Colorado
|
+$86K |
| 5 |
Barclays
London,
United Kingdom
|
+$24.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$112K |
| 2 |
Renaissance Technologies
New York
|
-$112K |
| 3 |
Bank of New York Mellon
New York
|
-$11.5K |
| 4 |
Morgan Stanley
New York
|
-$8.59K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$34 |
MBOT Hedge Fund Activity: Q1 2021 in Review
25 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2021, worth a combined $6.77M — up 28% from $5.28M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MBOT and 4 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $170K. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $112K sold.
- 25 institutional investors held Microbot Medical (MBOT) as of Q1 2021, down from 26 in Q4 2020.
- Funds reported $6.77M of Microbot Medical stock for Q1 2021, up 28% quarter-over-quarter.
- 4 funds opened new Microbot Medical positions in Q1 2021 and 5 closed out, a net change of -1 holder.
- The largest Microbot Medical buyer in Q1 2021 was Vanguard Group, an estimated $170K added.
- The largest Microbot Medical seller in Q1 2021 was Qube Research & Technologies (QRT), an estimated $112K sold.
Based on aggregated 13F filings for Q1 2021.